chrisvoncsefalvay/vaers-outcomes huggingface dataset:
One to two weeks post vax, the pt experienced peeling on hands and feet.  Peeling began on the front of hands by the fingers and progressed to the palms and feet. Unspecified medical attention was sought. The physician stated that she "does not know if Hep-B vaccine is the cause." She thinks that a streptococcal infection may be the cause. Additional information has been requested.
fatigue; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (fatigue). At the time of the report, FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
On 12/27 feet started feeling like pins sticking in then numbness & cold non stop. This sensation gradually moved up to the waistline area. Then total numbness, heaviness in legs, making it difficult to walk. There is also a raised, red rash that burns. Her symptoms are not better.
Approximately 30 hours after the shingles vaccination, I developed an upper respiratory infection, congestion, laryngitis, and fatigue. Ten days later, I still have some congestion and exhaustion. No fever.
Hospitalized 1/2/2022-1/5/2022 Chest pain, SOB, tachycardia
swollen brown/black, mostly black, size of orange first day 30OCT98 x 70mm round;6NOV98 size of egg, orange yellow around edges purple center;
shingles after vaccination; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of HERPES ZOSTER (shingles after vaccination) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (shingles after vaccination). At the time of the report, HERPES ZOSTER (shingles after vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.  No concomitant medication was provided.     This case was linked to MOD-2021-020217 (Patient Link).
Parent (who is an ophthalmologist) called 2 days after vaccine was given to state that there appeared to be cellulitis on the arm vaccine was given. Call was taken by my partner. Redness and swelling superior to the injection site that was warm to touch. Dr. started antibiotics for cellulitis after taking phone call.
get the shingles shot and they got shingles/suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in an unspecified number patients who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The age at vaccination was not reported. The reporter, knew several patients, who got the Shingles shot and they got the shingles. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. This case has been linked with case US2021AMR190782, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR190782:same reporter, different patient
Pediatric age 5-11 yrs old given to this adult patient. NDC given to this patient is 59267-4331-02. We discovered the error on 10/06/23  the morning following the dose. I've called patient twice and left voicemail. No adverse reaction reported by patient.
I had 2 shingles shots and still got the shingles/suspected vaccination failure; I had 2 shingles shots and still got the shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.  Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: The reporter was patient itself. The age group was not reported but was captured as adult as per vaccine indication. The patient received 2 doses of Shingles vaccine and experienced shingles  and had no pain. This case was considered as suspected vaccination failure as details regarding time to onset for target disease and laboratory confirmation were unknown at the time of reporting.
pt recv vax 29JAN96 & devel temp to 105, emesis p/motrin given then became stiff & eyes rolled back for 30 sec;pt devel cough & wheezing;CXR poss infiltrate
Back pain; Vaccination site hard; Headache; Injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back pain), VACCINATION SITE INDURATION (Vaccination site hard), HEADACHE (Headache) and VACCINATION SITE PAIN (Injection site pain) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. D391L20A) for COVID-19 vaccination.     The patient's past medical history included Laminectomy spinal in 1998.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced BACK PAIN (Back pain), VACCINATION SITE INDURATION (Vaccination site hard), HEADACHE (Headache) and VACCINATION SITE PAIN (Injection site pain). The patient was treated with ROSUVASTATIN ongoing since an unknown date at a dose of 20 mg. On 14-Jan-2021, BACK PAIN (Back pain), HEADACHE (Headache) and VACCINATION SITE PAIN (Injection site pain) had resolved. At the time of the report, VACCINATION SITE INDURATION (Vaccination site hard) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. The patient was treated with Aleve (naproxen).  Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Fever up to 101, body aches, chills, exhaustion, headache, nausea.
pt c/o chest pain, became diaphoretic, BP dec to 90/50;epi given;squad arrived w/in 10min of onset BP inc to 108/70;pt refused to be transported to hosp;
mild pain at the injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than a month after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received 1st dose of Shingrix a couple weeks ago, and experienced mild pain at the injection site. Consumer declined to provide further information for Safety report. Limited information provided. The reporter consented to follow up.
17 minutes after injection my tongue felt heavy and weird. Then my head felt heavy. Shortly after I passed out. The staff said my BP was in 180s. My normal BP is 100-110. Heart rate stayed around 115. Ice packs used and remained laying down for 30 minutes until heaviness passed. Oxygen remained normal although it felt hard to breathe. Just a heaviness on my chest.
ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 10/19/2022  &   11/25/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
3 days p/flu vax pt exp rt leg weakness & numbness; pt hospitalized;
At end of observation 15 min post vaccine Observation nurses report cleint stated she felt dizzy. reports had not eaten all day. Ate some candy, laid flat & elevated pt legs. Manual pressure 100 systolic with a 98% o2 on RA, 96.2F 63 P,  EMS called by Staff, pt reports feeling better manual pressure 110/65, pt remained alert oriented x 4 through episode, EMS arrived, pt refused hospital ambulated with EMS  vitals per EMS 127/76, 184BS, 68P
Vaccine was retrieved from pharmacy on the morning of 12/9/2021.  It was mistakenly grabbed from the area of the refrigerator that had been partitioned off for recently expired vaccine that is separate from the active vaccine refrigerator area.  Vaccine was brought to clinic in a temperature-controlled cooler that stored the vaccine at refrigerated temperatures (36F to 46F).  Vaccine was reconstituted and drawn up to administer.  Pharmacist gave vaccine and documented for CDC. It was discovered that vaccine was expired at this time.  Any additional vaccine from expired vials planned to give was postponed and remaining vaccine wasted.  No adverse effects noted post administration.  Called pharmacy who ensured expired vaccine was removed completely to prevent any further errors.  Notified facility administration and nursing staff taking care of patient of error.  Followed up again in less than 3 hours with facility staff with how patient was doing.  No adverse effects were noted.  Followed CDC guidance to contact manufacturer regarding error and gain additional information (Form CS-321629-AS).  Will follow-up with facility and patient tomorrow to make sure there have been no adverse effects/events post administration.
Arm is hurting really bad; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 10th May 2022, the patient received Shingles vaccine. In May 2022, less than a week after receiving Shingles vaccine, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was not recovered/not resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 11-May-2022 Reporter's comments: This case was reported by the patient via interactive digital media. The patient received Shingles shot on the day before the reporting. The patient's arm was hurting really bad. The patient was told to put an ice pack on it. The patient asked was that correct, the patient would have thought heat. Additional supportive information: From the narrative it seems that the patient had not used icepack but he/she was confirming if it was correct hence it was not coded as treatment.
Right Shoulder Bursitis; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of BURSITIS (Right Shoulder Bursitis) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BURSITIS (Right Shoulder Bursitis). At the time of the report, BURSITIS (Right Shoulder Bursitis) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were reported.  No concomitant medications were reported.
I have a physician friend who's 3 children were accidently given the adult COVID vaccine. The children have been pretty ill; I have a physician friend who's 3 children were accidently given the adult COVID vaccine. The children have been pretty ill; I have a physician friend who's 3 children were accidently given the adult COVID vaccine. The children have been pretty ill; This is a spontaneous report received from contactable reporter(s) (Physician) from medical information team.  A child patient received BNT162b2 (COMIRNATY), in Aug2022 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious) with onset 2022, outcome "unknown", PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (non-serious), OVERDOSE (non-serious) all with onset Aug2022, outcome "unknown" and all described as "I have a physician friend who's 3 children were accidently given the adult COVID vaccine. The children have been pretty ill".  Additional information: It was reported that 3 children were accidently given the adult COVID vaccine. The children were ill on the vaccinated week.  The information on the batch/lot number for [BNT162B2] has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201150442 similar report from same reporter;
Indurated, mildly tender to pressure area 1 1/2-2cms on posterior Left upper arm. Non fluctuant.
This case was forwarded by Crucell, no.: CVAE-043-2012. An initial report was received from a pharmacist on 26.Nov.2012 and concerns a 54-year-old female patient, who on an unspecified date received VIVOTIF (batch no.: not available). Medical history and concomitant medications were not reported. On an unspecified date, following administration of the vaccination, the patient experienced burning and uncomfortable sensation in the esophageal area. No further detail was provided. The outcome of the event was not known. The event was considered non-serious.
HA, ST, runny nose, and loss of taste/smell Symptoms began 4 days ago with dry tickly throat. Progressed to rhinorrhea and chest congestion over next few days. Developed sore throat yesterday with loss of smell. No fever or chills. starting 11/22/21
Information has been received from a nurse referring to a 16 month old male patient. The patient had no pertinent medical history or drug allergies. On 05-JAN-2016 the patient was vaccinated with VARIVAX (lot # L008273, expiration date 11-MAR-2017) 0.5 ml, subcutaneously. There was no concomitant therapy. On 13-MAY-2016, the patient developed herpes zoster on his right lower thigh as diagnosed by a physician on 16-MAY-2016 when the patient was seen. No treatment was given to the patient. No lab test was done. At the time of this report, the outcome of herpes zoster was unknown. Additional information has been requested.
After receiving 2nd COVID on 2/17/21 - pt started with chills, fever, decreased appetite, increased shortness of breath and pleurtic pain. Left sided chest pain. Patient started on xarelto 3/2/21 - using oxygen continous. Will continue on xarelto and follow up in clinic 6/17/21.
the patient reported significant pain, swelling, redness, and itching around the injection site; the patient reported significant pain, swelling, redness, and itching around the injection site; the patient reported significant pain, swelling, redness, and itching around the injection site; the patient reported significant pain, swelling, redness, and itching around the injection site; This spontaneous report as received from a pharmacist refers to a 79 year old male patient. No information was given regarding the patient's concurrent conditions, concomitant medications or medial history.   On 29-JUL-2020, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23), 0.5 milliliter for prophylaxis (dose, route of administration, lot number and expiration date were not reported).  On 30-JUL-2020, the patient experienced significant pain, swelling, redness, and itching around the injection site (injection site swelling, injection site pruritus, injection site erythema and injection site pain). It was unknown by the reporter if the patient received any treatment for the adverse events  The outcome of the events and the causal relationship between the events and vaccination with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) was not reported.  This is one of three cases from the same reporter. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; manufactureraddress:; manufacturercity:; manufacturerstate:; manufacturercountry:; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not suggest a causal association with the device or device constituent; Sender's Comments:  US-009507513-2008USA001325: US-009507513-2008USA001498:
Child had shots at approximately 3:45PM. Child and mom back in clinic at 4:09; child had wheezing, eyes swollen, chestpain, some difficulty swallowing. Epinephrine 1:1000 0.3 given. Patient sent to ER.
Patient stated she felt "under the weather" on 10/15/14.  On 10/16/14 she stated: LEFT ARM REACTION, HURTS, RED/WHITE HIVE, ITCHY...SORT OF LIKE A BEE STING.  This occurred two days after vaccine administration.
pt states had numbness both arms, legs, chest & back of head; had temp; arm swollen, no redness pt felt tired; had nausea 28MAY PM; diarrhea allday 29MAY;
Received second dose of vaccine and had minor symptoms X approximately 1 day.  On day 10 after 2nd dose of Pfizer vaccine developed vertigo requiring medical treatment and has not returned to work as of 1/29/21.
swelling at injection site, rash extending from right arm to right shoulder up to right side of neck,  severe muscle pain in right arm,  severe chest pains radiating from right arm throughout entire chest, racing heart rate, shortness of breathe.
AFTER RECEIVING VACCINES, MOM STILL IN LAB AND PATIENT STARTED TO WALK, FELL DIZZY AND FELL ON FLOOR.
On  8th day( Jan 28) injection site of Moderna Covid-19  started itching & slight rash.  On 9th day ( Jan 29) injection site has a more prnounced rash that is medium pink , warm & itching. Took a Benadryl.
fell; balance problem; Extreme Vertigo; Unable to walk; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration at right arm as a single dose on 18Mar2021 at 14:30 (at the age of 72-year-old) for COVID-19 immunisation. Relevant medical history of patient includes pancreatic cancer and received active chemo treatment and the patient had no known allergies. Concomitant medication of patient includes gabapentin (MANUFACTURER UNKNOWN), metformin (MANUFACTURER UNKNOWN), sertraline (ZOLOFT) and unspecified chemo drugs all for an unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 19Mar2021 at 08:30 after first dose of vaccination patient experienced extreme vertigo, unable to walk and on 22Mar2021 patient experienced balance problem, fell. It was reported that extreme vertigo started the next morning of vaccination. Patient was unable to walk without assistance. These lasted about 48 hours. It was now been 4 days since the vaccine and still had balance problems. Patient fell today when bending over. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Patient did not received treatment for events. The clinical outcome of extreme vertigo, unable to walk and balance problem was recovering at the time of report, fell was unknown.    No follow-up attempts are needed. No further information is expected.
pt recv vax & broke out in a raised fine rash on neck & face;also had inc temp x 3 days;rash had spread to arms, chest & stomach & upper back;saw MD 18MAY98 & med given cold & sore throat;
Tinnitus (whiring / grinding sound in the inner ear) is persistent in my left ear.  This started about an hour after I got home from the vaccine appointment.  It has been at a consistent level.  Basic attempts to solve it (ear cleaning, ear equalization via Valsalva maneuver, and messaging of the ear) have been ineffective.
Had GARDASIL and felt nausea and fait. Had not eaten in am. Gave juice, felt much better, released after 20 mins.
Pt with fever. Shortly after went to ED with hives at injection site. Tolerated seasonal flu shot weeks earlier.
Patient fainted and exhibited "seizure-like" activity approximately 2 minutes after vaccination.  Patient regained consciousness and felt better after resting.  Patient was released to home.
Rapid heart rate; Chest pain; This is a spontaneous report from a contactable consumer (patient). A 35-years-old female patient received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EW0153), dose 2 via an unspecified route of administration, administered in Arm Left on 20Apr2021 09:40 (at the age of 35-years-old) as DOSE 2, SINGLE for COVID-19 immunisation. Medical history included asthma like condition but not severe and allergy from an unknown date and unknown if ongoing. The patient previously received BNT162B2 on 23Mar2021 (Batch/ lot number: ER8730) as dose 1 single for COVID-19 immunisation. The patient's concomitant medications were not reported. The patient experienced rapid heart rate and (heart rate chest pain on an unspecified date. Patient got second vaccine and that was on 20Apr of this year and she have gotten the vaccine few hours later, she had rapid heart rate and she had not thought too much about it within the 48 hour. She thought it was just normal her body was reacting through it and four days later she started getting rapid heart rate, and she had chest pain since. Since, she got vaccine Pfizer she had, definitely have seen her doctor and she did have to wear a heart monitor for 14 days and so there was not any concern beside rapid heart rate. The condition was reported as persistent. The outcome of the events was reported as not recovered.  Follow-up (07Jul2021): Follow-up attempts completed. No further information expected; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021641291 similar report from same reporter